4-HO-DSBT

Source: Wikipedia, the free encyclopedia.
4-HO-DSBT
Identifiers
  • 3-[2-[di(butan-2-yl)amino]ethyl]-1H-indol-4-ol
JSmol)
  • CCC(C)N(CCc1c[nH]c2cccc(O)c12)C(C)CC
  • InChI=1S/C18H28N2O/c1-5-13(3)20(14(4)6-2)11-10-15-12-19-16-8-7-9-17(21)18(15)16/h7-9,12-14,19,21H,5-6,10-11H2,1-4H3
  • Key:SMKFHUHBZWMALV-UHFFFAOYSA-N

4-HO-DsBT (4-hydroxy-N,N-di-sec-butyltryptamine) is a

serotonin receptor agonist. It was first made by Alexander Shulgin and is mentioned in his book TiHKAL, but was never tested by him.[1] However it has subsequently been tested in vitro and unlike the n-butyl and isobutyl isomers which are much weaker, the s-butyl derivative retains reasonable potency, with a similar 5-HT2A receptor affinity to MiPT but better selectivity over the 5-HT1A and 5-HT2B subtypes.[2]

See also

References

  1. ^ 4-HO-DBT TiHKAL entry
  2. S2CID 24188017
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=4-HO-DSBT&oldid=1195792817"